Wednesday March 11, 2026
13:00-14:30
PLENARY INDUSTRY 01 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 117
14:30-14:40
SHORT BREAK
Exhibition Area
14:40-16:10
PARALLEL INDUSTRY 01 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 112
PARALLEL INDUSTRY 02 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 113
PARALLEL INDUSTRY 03 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 114
PARALLEL INDUSTRY 04 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 115
PARALLEL INDUSTRY 05 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 212
SCIENTIFIC PARALLEL SESSION - TBC
Hall 116
16:10-16:20
BREAK TO CHANGE HALLS
Exhibition Area
16:20-17:50
PLENARY INDUSTRY 02 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 117
17:50-18:00
SHORT BREAK
Exhibition Area
18:00-18:40
OPENING SESSION
Auditorium
18:40-19:00
OPENING CEREMONY
Auditorium
19:00-20:00
WELCOME RECEPTION
Exhibition Area
Thursday March 12, 2026
08:00-09:00
HOT FROM THE OVEN
Auditorium
09:00-10:00
SCIENTIFIC PLENARY SESSION 01: TRANSFORMING DIABETES MANAGEMENT WITH ARTIFICIAL INTELLIGENCE (AI)
Auditorium
10:00-10:30
COFFEE BREAK
Exhibition Area
10:30-12:00
PLENARY INDUSTRY 03 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Auditorium
12:00-13:00
LUNCH BREAK
Exhibition Area
13:00-14:30
SCIENTIFIC PARALLEL SESSION 01: SCREENING AND TREATMENT OPTIONS FOR DELAYING ONSET OF TYPE 1 DIABETES
Hall 117
SCIENTIFIC PARALLEL SESSION 02: USE OF TECHNOLOGY IN OLDER ADULTS WITH DIABETES
Hall 112
SCIENTIFIC PARALLEL SESSION 03: REAL LIFE USE OF CONTINUOUS GLUCOSE MONITORING (CGM)
Hall 211
PARALLEL INDUSTRY 06 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 113
PARALLEL INDUSTRY 07: (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 114
SCIENTIFIC PARALLEL SESSION 04: UPDATES ON DIABETES MANAGEMENT AND FEMALES’ HEALTH
Hall 115
ORAL PRESENTATIONS 01
Hall 116
SCIENTIFIC PARALLEL SESSION 05: EXERCISE PHYSIOLOGY AND METABOLISM IN DIABETES: FROM THEORY TO CLINICAL APPLICATION
Hall 212
14:30-14:40
BREAK TO CHANGE HALLS
Exhibition Area
14:40-16:10
PLENARY INDUSTRY 04 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Auditorium
16:10-16:40
COFFEE BREAK
Exhibition Area
16:40-18:10
ORAL PRESENTATIONS 02
Hall 212
SCIENTIFIC PARALLEL SESSION 06: CLOSED-LOOP SYSTEMS – WHERE ARE WE NOW?
Hall 117
SCIENTIFIC PARALLEL SESSION 07: THE LEONA M. AND HARRY B. HELMSLEY CHARITABLE TRUST SESSION - PUSHING THE FIELD OF EXERCISE FORWARD FOR PEOPLE LIVING WITH TYPE 1 DIABETES
Hall 112
SCIENTIFIC PARALLEL SESSION 08: THE USE OF TECHNOLOGY IN TREATING TYPE 2 DIABETES
Hall 211
SCIENTIFIC PARALLEL SESSION 09: GLOBAL STAGES OF SCREENING OF TYPE 1 DIABETES
Hall 115
PARALLEL INDUSTRY 08 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 113
SCIENTIFIC PARALLEL SESSION 10: NUTRITION AND FOOD TECHNOLOGIES
Hall 116
PARALLEL INDUSTRY 09 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 114
Friday March 13, 2026
08:30-09:20
PLENARY INDUSTRY 05 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 117
09:20-09:30
BREAK TO CHANGE HALLS
Exhibition Area
09:30-10:30
ORAL PRESENTATIONS 03
Hall 116
SCIENTIFIC PARALLEL SESSION 11: FROM PREDICTION TO DIABETES COMPLICATIONS
Hall 117
SCIENTIFIC PARALLEL SESSION 12: DEBATE: HBA1C AND NOT CGM SHOULD BE THE GOLD STANDARD TO EVALUATE GLUCOSE CONTROL
Hall 112
ORAL PRESENTATIONS 04
Hall 212
SCIENTIFIC PARALLEL SESSION 13: DATA INTEROPERABILITY
Hall 211
PARALLEL INDUSTRY 10 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 113
SCIENTIFIC PARALLEL SESSION 14: REVOLUTIONIZING DIABETES CARE: ARTIFICIAL INTELLIGENCE, MACHINE LEARNING AND CONTINUOUS GLUCOSE MONITORING IN PRACTICE
Hall 115
PARALLEL INDUSTRY 11 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 114
10:30-11:00
COFFEE BREAK
Exhibition Area
11:00-12:30
PLENARY INDUSTRY 06 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Auditorium
12:30-13:30
LUNCH BREAK
Exhibition Area
13:30-15:00
SCIENTIFIC PLENARY SESSION 02: ATTD YEARBOOK SESSION
Auditorium
15:00-15:15
BREAK TO CHANGE HALLS
Exhibition Area
15:15-16:45
PLENARY INDUSTRY 07 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 117
16:45-17:15
COFFEE BREAK
Exhibition Area
17:15-18:45
SCIENTIFIC PARALLEL SESSION 15: BEYOND THE BASICS: ELEVATING DIABETES NURSING
Hall 117
SCIENTIFIC PARALLEL SESSION 16: PREGNANCY AND DIABETES
Hall 112
SCIENTIFIC PARALLEL SESSION 17: MANAGING OVERWEIGHT & OBESITY IN TYPE 1 DIABETES
Hall 211
SCIENTIFIC PARALLEL SESSION 18: BREAKTHROUGH T1D (JDRF) SESSION - CELL REPLACEMENT THERAPY: FUNCTIONAL CURE FOR TYPE 1 DIABETES – HOW FAR ARE WE?
Hall 115
SCIENTIFIC PARALLEL SESSION 19: ADJUNCT THERAPIES WITH AUTOMATED INSULIN DELIVERY
Hall 116
SCIENTIFIC PARALLEL SESSION 20: EQUITY AND INNOVATION IN DIABETES: CHALLENGES, DISPARITIES, AND BREAKTHROUGHS
Hall 212
PARALLEL INDUSTRY 12 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 113
PARALLEL INDUSTRY 13 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 114
Saturday March 14, 2026
08:30-09:20
PLENARY INDUSTRY 08 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 117
09:20-09:30
BREAK TO CHANGE HALLS
Exhibition Area
09:30-11:00
ORAL PRESENTATIONS 05
Hall 115
SCIENTIFIC PARALLEL SESSION 21: REFINING CARE OF TYPE 1 DIABETES
Hall 117
SCIENTIFIC PARALLEL SESSION 22: UPDATES ON HYPO- AND HYPERGLYCEMIA
Hall 112
SCIENTIFIC PARALLEL SESSION 23: CARDIOVASCULAR DISEASE IN TYPE 1 DIABETES
Hall 211
ORAL PRESENTATIONS 06
Hall 116
SCIENTIFIC PARALLEL SESSION 24: AUTOMATED INSULIN DELIVERY (AID)
Hall 114
ORAL PRESENTATIONS 07
Hall 212
PARALLEL INDUSTRY 14 - Part 1 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 113
11:00-11:30
COFFEE BREAK
Exhibition Area
11:30-13:00
ORAL PRESENTATIONS 08
Hall 115
SCIENTIFIC PARALLEL SESSION 25: CHALLENGES OF HEALTH CARE PROVIDERS IN TREATING PEOPLE WITH DIABETES
Hall 117
SCIENTIFIC PARALLEL SESSION 26: NAVIGATING EARLY TYPE 1 DIABETES – FROM SCREENING TO MANAGEMENT
Hall 112
ORAL PRESENTATIONS 09
Hall 116
SCIENTIFIC PARALLEL SESSION 27: CONTINUOUS GLUCOSE MONITORING (CGM) OUTSIDE THE TRADITIONAL AREAS
Hall 211
SCIENTIFIC PARALLEL SESSION 28: BREAKTHROUGH T1D (JDRF) SESSION: BRIDGING THE GAP BETWEEN ACADEMIA AND INDUSTRY IN DIABETES TECHNOLOGY
Hall 114
ORAL PRESENTATIONS 10
Hall 212
PARALLEL INDUSTRY 14 - Part 2 (INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT)
Hall 113
13:00-13:45
LUNCH BREAK
Exhibition Area
13:45-15:15
ORAL PRESENTATIONS 11
Hall 115
SCIENTIFIC PARALLEL SESSION 29: INDIA D-TECH SESSION
Hall 117
SCIENTIFIC PARALLEL SESSION 30: OPPORTUNITIES AND HURDLES FOR SMART PENS
Hall 112
SCIENTIFIC PARALLEL SESSION 31: ISPAD SESSION - PEDIATRIC DIABETES: UPDATES ON TECHNOLOGY, GUIDELINES, AND GLOBAL OUTREACH
Hall 211
SCIENTIFIC PARALLEL SESSION 32: TBA
Hall 113
SCIENTIFIC PARALLEL SESSION 33: TBA
Hall 114
ORAL PRESENTATIONS 12
Hall 116
ORAL PRESENTATIONS 13
Hall 212
15:15-15:25
SHORT BREAK
Exhibition Area
15:25-16:25
SCIENTIFIC PLENARY SESSION 03: ADVANCEMENTS IN TYPE 1 DIABETES: FROM PATHOGENESIS TO THERAPY
Hall 211
16:25-17:00
CLOSING REMARKS
Hall 211